Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 May;50(5):1044–1049. doi: 10.1172/JCI106575

Mediators of histamine release from human platelets, lymphocytes, and granulocytes

Michael T Kelly 1, R Russell Martin 1, Arthur White 1
PMCID: PMC292026  PMID: 4101589

Abstract

Lysates of mixed human leukocyte suspensions released histamine from intact human leukocytes in vitro. Microgram quantities of leukocyte lysate protein released up to 90% of the total available histamine. The mixed leukocyte lysates were separated by differential centrifugation into nuclear (800 g pellet), lysosomal (25,000 g pellet), and postlysosomal supernatant (25,000 g supernatant) fractions. The degree of separation of the lysosomal from the other two fractions was assessed by measuring the relative activities of four lysosomal enzymes. The average distribution of enzyme activity was 11 ±2% (mean ±1 SD), 72 ±10%, and 17 ±8% for the nuclear, lysosomal, and supernatant fractions respectively. The histamine-releasing activity was equally distributed between the lysosomal and supernatant fractions, each of which had 5-fold greater activity than the nuclear fraction.

Purified suspensions of platelets, lymphocytes, and granulocytes were prepared, and the lysates of these suspensions all had histamine-releasing activity. Centrifugation at 100,000 g for 18 hr sedimented the histamine-releasing activity from all three types of lysate. After 20% ethanol fractionation for the preparation of cationic protein, only the activity from the platelet lysates was found in the 20% ethanol insoluble fraction.

These mediators of histamine release from human platelets, lymphocytes, and granulocytes may play a role in the development of the vasodilation and increased vascular permeability which characterize the acute inflammatory response.

Full text

PDF
1044

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARCHER G. T. Release of histamine from mast cells by tissue extracts. Nature. 1958 Sep 13;182(4637):726–727. doi: 10.1038/182726a0. [DOI] [PubMed] [Google Scholar]
  2. COHN Z. A., HIRSCH J. G. The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes. J Exp Med. 1960 Dec 1;112:983–1004. doi: 10.1084/jem.112.6.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chodirker W. B., Bock G. N., Vaughan J. H. Isolation of human PMN leukocytes and granules: observations on early blood diluion and on heparin. J Lab Clin Med. 1968 Jan;71(1):9–19. [PubMed] [Google Scholar]
  4. Dunn W. B., Spicer S. S. Histochemical demonstration of sulfated mucosubstances and cationic proteins in human granulocytes and platelets. J Histochem Cytochem. 1969 Oct;17(10):668–674. doi: 10.1177/17.10.668. [DOI] [PubMed] [Google Scholar]
  5. Goth A. Carbohydrate metabolism and histamine release. Fed Proc. 1967 Jan-Feb;26(1):222–223. [PubMed] [Google Scholar]
  6. HURLEY J. V. SUBSTANCES PROMOTING LEUKOCYTE EMIGRATION. Ann N Y Acad Sci. 1964 Aug 27;116:918–935. doi: 10.1111/j.1749-6632.1964.tb52558.x. [DOI] [PubMed] [Google Scholar]
  7. Henson P. M. Role of complement and leukocytes in immunologic release of vasoactive amines from platelets. Fed Proc. 1969 Sep-Oct;28(5):1721–1728. [PubMed] [Google Scholar]
  8. Janoff A., Schaefer S. Mediators of acute inflammation in leucocyte lysosomes. Nature. 1967 Jan 14;213(5072):144–147. doi: 10.1038/213144a0. [DOI] [PubMed] [Google Scholar]
  9. LICHTENSTEIN L. M., OSLER A. G. STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN. J Exp Med. 1964 Oct 1;120:507–530. doi: 10.1084/jem.120.4.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Levy D. A. Studies of histamine release from human leukocytes. Ann Allergy. 1969 Oct;27(10):511–518. [PubMed] [Google Scholar]
  12. Martin R. R., White A. The in vitro release of leukocyte histamine by staphylococcal antigens. J Immunol. 1969 Feb;102(2):437–441. [PubMed] [Google Scholar]
  13. Nachman R. L., Weksler B., Ferris B. Increased vascular permeability produced by human platelet granule cationic extract. J Clin Invest. 1970 Feb;49(2):274–281. doi: 10.1172/JCI106237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. RABINOWITZ Y. SEPARATION OF LYMPHOCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES ON GLASS COLUMNS, INCLUDING TISSUE CULTURE OBSERVATIONS. Blood. 1964 Jun;23:811–828. [PubMed] [Google Scholar]
  15. Scherer J., Janoff A. Mediators of inflammation in leukocyte lysosomes. VII. Observations on mast cell-rupturing agents in different species. Lab Invest. 1968 Feb;18(2):196–202. [PubMed] [Google Scholar]
  16. Seegers W., Janoff A. Mediators of inflammation in leukocyte lysosomes. VI. Partial purification and characterization of a mast cell-rupturing component. J Exp Med. 1966 Nov 1;124(5):833–849. doi: 10.1084/jem.124.5.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. UVNAES B. RELEASE PROCESSES IN MAST CELLS AND THEIR ACTIVATION BY INJURY. Ann N Y Acad Sci. 1964 Aug 27;116:880–890. doi: 10.1111/j.1749-6632.1964.tb52554.x. [DOI] [PubMed] [Google Scholar]
  18. Uvnäs B. Mode of binding and release of histamine in mast cell granules from the rat. Fed Proc. 1967 Jan-Feb;26(1):219–221. [PubMed] [Google Scholar]
  19. Zeya H. I., Spitznagel J. K. Cationic proteins of polymorphonuclear leukocyte lysosomes. II. Composition, properties, and mechanism of antibacterial action. J Bacteriol. 1966 Feb;91(2):755–762. doi: 10.1128/jb.91.2.755-762.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES